Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34864
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ermongkonchai, Tai | - |
dc.contributor.author | Ha, Phil | - |
dc.contributor.author | French, Janine | - |
dc.date | 2024 | - |
dc.date.accessioned | 2024-01-19T05:25:01Z | - |
dc.date.available | 2024-01-19T05:25:01Z | - |
dc.date.issued | 2024-01-12 | - |
dc.identifier.citation | BMJ Case Reports 2024-01-12; 17(1) | en_US |
dc.identifier.issn | 1757-790X | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/34864 | - |
dc.description.abstract | We present the case of a woman in her 60s with Child-Pugh C cirrhosis who developed pericardial tamponade during an admission for a haemothorax secondary to a mechanical fall. The patient developed haemodynamic compromise with a rapid decline in renal function. During an open subxiphoid drain tube insertion, a pre-existing peritoneopericardial communication was noted, with ascites in the peritoneal cavity on view. The serum ascites albumin gradient was 14 g/L. Maximal medical therapy was commenced including diuresis and albumin, with adjunctive terlipressin infusion which restored her baseline renal function and resolved the effusion. We believe this is the first case report of using open drainage, maximal medical therapy and terlipressin to successfully treat hepatic hydropericardium and its subsequent renal compromise. | en_US |
dc.language.iso | eng | - |
dc.subject | Cirrhosis | en_US |
dc.subject | Gastrointestinal system | en_US |
dc.subject | Pericardial disease | en_US |
dc.subject | Portal hypertension | en_US |
dc.title | Management of hepatic hydropericardium with open drainage, maximal medical therapy and terlipressin. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | BMJ Case Reports | en_US |
dc.identifier.affiliation | Gastroenterology and Hepatology | en_US |
dc.identifier.doi | 10.1136/bcr-2023-256908 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-2210-5773 | en_US |
dc.identifier.pubmedid | 38216161 | - |
dc.description.volume | 17 | - |
dc.description.issue | 1 | - |
dc.subject.meshtermssecondary | Terlipressin/therapeutic use | - |
dc.subject.meshtermssecondary | Ascites/drug therapy | - |
dc.subject.meshtermssecondary | Ascites/etiology | - |
dc.subject.meshtermssecondary | Liver Cirrhosis/complications | - |
dc.subject.meshtermssecondary | Pericardial Effusion/complications | - |
dc.subject.meshtermssecondary | Edema/complications | - |
dc.subject.meshtermssecondary | Drainage/adverse effects | - |
dc.subject.meshtermssecondary | Lypressin/therapeutic use | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Victorian Liver Transplant Unit | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.